These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37445604)

  • 1. Gender Influences Gut Microbiota among Patients with Irritable Bowel Syndrome.
    Pecyna P; Gabryel M; Mankowska-Wierzbicka D; Nowak-Malczewska DM; Jaskiewicz K; Jaworska MM; Tomczak H; Rydzanicz M; Ploski R; Grzymislawski M; Dobrowolska A; Gajecka M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review.
    Duan R; Zhu S; Wang B; Duan L
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00012. PubMed ID: 30829919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
    J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 5. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
    Kim GH; Lee K; Shim JO
    Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data.
    Chen H; Ou R; Tang N; Su W; Yang R; Yu X; Zhang G; Jiao J; Zhou X
    J Transl Med; 2023 Feb; 21(1):117. PubMed ID: 36774467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.
    Yao C; Li Y; Luo L; Xie F; Xiong Q; Li T; Yang C; Feng PM
    Dig Dis Sci; 2023 Jan; 68(1):106-127. PubMed ID: 35503487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.
    Heitkemper MM; Cain KC; Shulman RJ; Burr RL; Ko C; Hollister EB; Callen N; Zia J; Han CJ; Jarrett ME
    Benef Microbes; 2018 Apr; 9(3):345-355. PubMed ID: 29633639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
    Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
    World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiomics Analysis Reveals Gut Virome-Bacteria-Metabolite Interactions and Their Associations with Symptoms in Patients with IBS-D.
    Xie P; Luo M; Fan J; Xiong L
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients.
    Lee SM; Kim N; Yoon H; Kim YS; Choi SI; Park JH; Lee DH
    Gut Liver; 2021 Mar; 15(2):253-261. PubMed ID: 32457278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.
    Nilholm C; Manoharan L; Roth B; D'Amato M; Ohlsson B
    United European Gastroenterol J; 2022 May; 10(4):363-375. PubMed ID: 35484927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome.
    Mei L; Zhou J; Su Y; Mao K; Wu J; Zhu C; He L; Cui Y
    BMC Gastroenterol; 2021 Mar; 21(1):105. PubMed ID: 33663411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.
    Labus JS; Osadchiy V; Hsiao EY; Tap J; Derrien M; Gupta A; Tillisch K; Le Nevé B; Grinsvall C; Ljungberg M; Öhman L; Törnblom H; Simren M; Mayer EA
    Microbiome; 2019 Mar; 7(1):45. PubMed ID: 30898151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study.
    Zhou J; Wei H; Zhou A; Xiao X; Xie X; Tang B; Lin H; Tang L; Meng R; Yuan X; Zhang J; Huang C; Huang B; Liao X; Zhong T; He S; Gu S; Yang S
    J Transl Med; 2024 Jan; 22(1):98. PubMed ID: 38263117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
    Hou Y; Dong L; Lu X; Shi H; Xu B; Zhong W; Ma L; Wang S; Yang C; He X; Zhao Y; Wang S
    Dig Dis Sci; 2022 Dec; 67(12):5580-5592. PubMed ID: 35879512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.